Phar­ma brands dom­i­nate ‘new’ TV com­mer­cial list for first half of 2023, ad track­er re­ports

Up-and-com­ing brands from Ab­b­Vie, Bris­tol My­ers Squibb and Eli Lil­ly got a lot of net­work TV air­time in the first half of 2023. Com­mer­cials for Skyrizi for two in­di­ca­tions, So­tyk­tu and Moun­jaro ranked in the top 10 for most-viewed, first-time TV cam­paigns in re­al­time ad track­er iS­pot.tv’s first-half re­port.

Ab­b­Vie’s Skyrizi for Crohn’s, with a roller coast­er-themed ad and the re­minder that “Con­trol means every­thing,” was sec­ond on iS­pot’s list with more than 6 bil­lion im­pres­sions. Bris­tol My­ers’ new­ly ap­proved So­tyk­tu to treat pso­ri­a­sis ranked in third place, with two TV spots de­but­ing dur­ing the six months — one launched in Feb­ru­ary dur­ing the Gram­my Awards and an­oth­er in May — with 4.3 bil­lion im­pres­sions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER